Hepatitis B vaccination for patients with chronic hepatitis B

Hepatitis B vaccination for patients with chronic hepatitis B - HBV vaccination for chronic hepatitis B

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005978

Enrollment

Registered

2011-08-01

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Hepatitis B vaccination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Chronic hepatitis B 2) Treatment with nucleoside analogues more than 3 months 3) Serum HBV-DNA<3 logIU/mL by Taqman PCR method 4) 20 years old or more 5) Possible to treat in Kyoto University Hospital 6) With written informed consent

Exclusion criteria

Exclusion criteria: 1) fever 2) severe acute disease 3) past history of anaphylactic reaction to hepatitis B vaccine 4) pregnancy 5) inappropriate cases judged by doctor

Design outcomes

Primary

Measure	Time frame
Rate of patients who are positive for anti-HBs antibody at 24 months after the initiation of hepatitis B vaccination	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026